The impact of pharmaceutical innovation on cancer mortality in Mexico, 2003–2013

Latin American Economic Review

Table 4 Estimates of β _k parameters of Eq. (7), ∆MORT_s = β _k ∆CUM_NCE_k _s + γ ∆INCIDENCE_1_s + π ∆MORT_PRE_s + δ′ + ε _s′ excluding and including ∆MORT_PRE_s

Row	Lag	Parameter	Estimate	Std. err.	T	p value
			Without control for ∆MORT_PREV
22	0	β ₀	− 0.26361	0.09837	− 2.67978	0.03155
23	3	β ₃	− 0.26209	0.10704	− 2.44851	0.0442
24	6	β ₆	− 0.16993	0.10048	− 1.69117	0.13465
25	9	β ₉	− 0.20238	0.09249	− 2.18828	0.06484
26	12	β ₁₂	− 0.26289	0.07605	− 3.45699	0.01059
27	15	β ₁₅	− 0.27366	0.08422	− 3.24925	0.01407
28	18	β ₁₈	− 0.27399	0.12188	− 2.24806	0.05937
			With control for ∆MORT_PREV
29	0	β ₀	− 0.23336	0.09856	− 2.36765	0.0557
30	3	β ₃	− 0.22552	0.11339	− 1.98885	0.09387
31	6	β ₆	− 0.12894	0.11267	− 1.14446	0.29603
32	9	β ₉	− 0.16884	0.10131	− 1.66657	0.14665
33	12	β ₁₂	− 0.23641	0.08384	− 2.81985	0.03036
34	15	β ₁₅	− 0.26438	0.06602	− 4.00487	0.00708
35	18	β ₁₈	− 0.3807	0.03866	− 9.84795	0.00006